| Financial Year |
March 31 2022 |
| Monetary Funds |
408,671,601.71 |
| Held-for-trading Financial Assets |
1,226,120.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
101,565,023.79 |
| Advances to Suppliers |
24,662,479.96 |
| Other Receivables |
1,987,069.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,499,303.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
63,211,728.70 |
| Total Current Assets |
748,753,406.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
73,481,495.77 |
| Investment Properties |
-- |
| Fixed Assetes |
386,865,398.65 |
| Under-construction Projects |
80,910,579.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,719,886.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,374,874.69 |
| Other Non-Current Assets |
40,132,162.40 |
| Sub-Total of Non-Current Assets |
759,484,398.29 |
| Total Assets |
1,508,237,804.63 |
| Short-Term Loans |
150,397,194.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,039,839.43 |
| Accounts Payable |
52,820,895.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,867,998.27 |
| Taxes Payable |
7,378,631.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,640,712.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,500,000.00 |
| Other Current Liabilities |
393.34 |
| Sub-Total of Current Liabilities |
288,655,858.56 |
| Long-term Loans |
76,764,196.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
222,549.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,096,995.05 |
| Total Liabilities |
381,752,853.61 |
| Paid-In Capital(Or Share Stock) |
121,150,000.00 |
| Capital Surplus |
671,235,515.40 |
| Surplus Reserve |
28,062,194.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
279,412,104.40 |
| Minority Stockholder's Interest |
21,023,168.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,105,461,782.94 |
| Owner's Equity（Stockholder's Equity） |
1,126,484,951.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,508,237,804.63 |
